Inactive Instrument
ARYx Therapeutics, Inc. Share Price Other OTC
Stocks
ARYX
US0433871094
Biotechnology & Medical Research
OTC Markets Traded| Market Cap | 90.35L 78.95L 72.99L 67.43L 1.27Cr 87Cr 1.29Cr 8.7Cr 3.42Cr 42Cr 3.39Cr 3.32Cr 146.32Cr | P/E 2008 |
-1.76x | P/E 2009 | -2.66x |
|---|---|---|---|---|---|
| Enterprise Value | 1.14Cr 99.67L 92.14L 85.13L 1.6Cr 109.56Cr 1.63Cr 11Cr 4.31Cr 54Cr 4.28Cr 4.19Cr 184.72Cr | EV / Sales 2008 |
40,19,605x | EV / Sales 2009 | - |
| Free-Float |
100% | Yield 2008 * |
-
| Yield 2009 | - |
| 1 day | +47.06% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +47.06% | +4.62% | - | - | 33 | |
| +6.05% | +3.69% | +65.28% | +89.94% | 5.35TCr | |
| +0.21% | -6.28% | +56.18% | +127.90% | 5.42TCr | |
| +0.88% | -2.55% | +7.92% | +433.79% | 2.37TCr | |
| +1.09% | -3.65% | -18.15% | -16.07% | 2.28TCr | |
| +2.36% | +1.06% | +43.34% | -6.14% | 1.95TCr | |
| -2.29% | -1.92% | +35.57% | -29.14% | 1.78TCr | |
| -4.00% | -7.88% | +175.60% | +343.60% | 1.6TCr | |
| -1.15% | -4.83% | +46.53% | +627.30% | 1.54TCr | |
| -0.37% | -2.13% | +22.56% | +188.11% | 1.41TCr | |
| Average | +5.01% | -1.47% | +48.31% | +195.48% | 2.63TCr | |
| Weighted average by Cap. | +1.28% | -0.46% | +49.11% | +163.71% |
| 2008 | 2009 | |
|---|---|---|
| Net sales | 19.72 17.24 15.93 14.72 27.72 1.89T 28.23 190.02 74.55 927.71 74.09 72.45 3.19T | - |
| Net income | -3.12Cr -2.73Cr -2.52Cr -2.33Cr -4.39Cr -299.86Cr -4.47Cr -30Cr -12Cr -146.83Cr -12Cr -11Cr -505.58Cr | -3.32Cr -2.9Cr -2.68Cr -2.48Cr -4.66Cr -318.58Cr -4.75Cr -32Cr -13Cr -156Cr -12Cr -12Cr -537.14Cr |
| Net Debt | -29.9 -26.13 -24.16 -22.32 -42.03 -2.87T -42.79 -288.11 -113.04 -1.41T -112.33 -109.85 -4.84T | 2.37 2.07 1.92 1.77 3.33 227.74 3.39 22.84 8.96 111.52 8.91 8.71 383.99 |
Employees
-
Choose MarketScreener 
